#flu resistance

[viraldiseasehelp-blog]

Influenza viruses with resistant to the newest drug

Doctors in Japan began using a new flu drug called Xofluza since March 2018. According to the creators of medication, it's able to overcome the disease in the shortest time. The drug was also approved for sale in other countries, for example, in the United States.

Baloxavir marboxyl is the active ingredient of the new remedy. Many experts found Xofluza a real breakthrough in pharmacology. Its principle of action was different from other flu drugs. It was also important that patient could take only one dose of the remedy. This made the medication much more convenient than the analogues on the market. The drug reduced the duration of the disease and the severity of the symptoms, alleviating the condition of the patients.

Not only the scientific and patient community responded to the appearance of the new drug. Researchers from Japan have discovered influenza viruses in recent months, whose strains have resistance to Xofluza. Scientists noted, mutated influenza viruses that were not affected by baloxavir marboxyl were found in about one in four (about 23.4%) of the study participants, which they examined. Researchers examined schoolchildren - children under the age of 12 years. The discovered strains were 120 times more resistant to the new drug, than influenza viruses without mutations.